Treatment of toad venom poisoning with digoxin-specific Fab fragments

Chest

Volumn 110, Issue 5, 1996, Pages 1282-1288

  Brubacher, Jeffrey R ^a,e   Ravikumar, Padinjarekuttu R ^b   Bania, Theodore ^a,f   Heller, Michael B ^b,c   Hoffman, Robert S ^a,d  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b New York City Poison Control   (United States)

^c Department of Oral Pathology   (United States)

^d BELLEVUE HOSPITAL CENTER   (United States)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f Department of Emergency Medicine   (United States)

Author keywords

bufodienolides; cardenolides; cardiac glycosides; digoxin; digoxin Fab fragments; toad venom

Indexed keywords

AMPHIBIAN VENOM; APHRODISIAC AGENT; BUFADIENOLIDE; CARDENOLIDE; CARDIAC GLYCOSIDE; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT;

ADOLESCENT; ADULT; ARTICLE; BRADYCARDIA; CAUSE OF DEATH; CHINESE MEDICINE; CLINICAL ARTICLE; HEART ARRHYTHMIA; HUMAN; INTOXICATION; MALE; PRIORITY JOURNAL; TOAD; TRADITIONAL MEDICINE; TREATMENT OUTCOME; VOMITING;

EID: 0029821328     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.5.1282     Document Type: Article

References (45)

1. Chen KK, Kovarikova A. Pharmacology and toxicology of toad venom. J Pharmaceut Sci 1967; 56:1535-41
2. Huang KC, Chan Su, In: Huaug KC, ed. The pharmacology of Chinese herbs. Boca Raton, Fla: CRC Press, 1993; 114-17
3. Morishita S, Shoji M, Oguni Y, et al. Pharmacological actions of 'Kyushin,' a drug containing toad venom: cardiotonic and arrhythmogenic effects, and excitatory effect on respiration. Am J Chin Med 1992; 20:245-56
4. Yei CC, Deng JF. Toad or toad cake intoxication in Taiwan: report of four cases. J Formos Med Assoc 1993;92:S135-39
5. Hitt M, Ettinger DD, Toad toxicity. N Engl J Med 1986; 314:1517
6. Anonymous. Family eats toad: one dies of poisoning: child is victim of strange food. Honolulu Star Bulletin 1935; April 18:1
7. Chern MS, Ray CY, Wu D. Biologic intoxication due to digitalislike substance after ingestion of cooked toad soup. Am J Cardiol 1991; 67:443-44
8. Licht LE. Death following possible ingestion of toad eggs. Toxicon 1967; 5:141-42
9. Lyttle T. Misuse and legend in the 'toad licking' phenomenon. Int J Addict 1993; 28:521-38
10. Hoch JH. A survey of cardiac glycosides and genins. Charleston: University of South Carolina Press, 1961
11. Bania T, Gruber P, Howland MA, et al. Rock Hard: a fatal plant aphrodisiac [abstract]. Vet Hum Toxicol 1993; 35:328
12. Brubacher JR, Hoffman RS, Bania T, et al. Deaths associated with a purported aphrodisiac - New York City, February 1993-May 1995. MMWR 1995; 44:853-55
13. De Smet PA, Rivier L. Intoxicating snuffs of the Venezuelan Piaroa Indians. J Psychoact Drugs 1985; 17:93-103
14. Yoshida S, Kamano Y, Sakai T. Studies on the surface anesthetic activity of bufadienolides isolated from Ch'an Su. Chem Pharm Bull 1976; 24:1714-17
15. Anonymous. "U.S. says 4 died in New York eating an alleged aphrodisiac." New York Times, 1995; Nov 25: page 1
16. Fabing HD, Hawkins JR. Intravenous bufotenine injection in the human being. Science 1956; 123:886-87
17. Osterloh J, Herold S, Pond S. Oleander interference in the digoxin radioimmunoassay in a fatal ingestion. JAMA 1982; 247:1596-97
18. Hastreiter AR, Van Der Horst RL, Chow-Tung E. Digitalis toxicity in infants and children. Pediatr Cardiol 1984; 5:131-48
19. Cheung K, Hinds JA, Duffy P. Detection of poisoning by plantorigin cardiac glycoside with the Abbot TDx analyzer. Clin Chem 1989; 35:295-97
20. Radford DJ, Cheung K, Urech R, et al. Immunologic detection of cardiac glycosides in plants. Aust Vet J 1994; 71:236-38
21. Haynes BE, Bessen HA, Wightman WD, et al. Oleander tea: herbal draught of death. Ann Emerg Med 1985; 14:350-53
22. Tuncok Y, Kozan O, Cavdar C, et al. Urginea maritima (Squill) toxicity. J Toxicol Clin Toxicol 1995; 33:83-6
23. Fushimi R, Koh T, Iyam S, et al. Digoxin-like immunoreactivity in Chinese medicine. Ther Drug Monitor 1990; 12:242-45
24. Koobatian TJ, Roberts JR, Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances. Acad Emerg Med 1995; 2:322-26
25. Valdes R, Graves SW, Brown BA, et al. Endogenous substances in newborn infants causing false positive digoxin measurements. J Pediatr 1983; 102:947-50
26. Kerkey SA, Poston L, Wolfe CD, et al. A longitudinal study of maternal digoxin-like immunoreactive substances in normotensive pregnancy and pregnancy induced hypertension. Am J Obstet Gynecol 1990; 162:783-87
27. Graves SW, Brown B, Valdes R. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 1983; 99:604-08
28. Nanji AA, Greenway DC. Falsely raised plasma digoxin concentrations in liver disease. BMJ 1985; 290:432-33
29. Shilo L, Adawi A, Solomon G, et al. Endogenous digoxin-like immunoreactivity in congestive heart failure. BMJ 1987; 295:415-16
30. Antman EM, Wenger TL, Butler VP, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific FAB antibody fragments. Circulation 1990; 81:1744-52
31. Woolf AD, Wenger T, Smith TW, et al. The use of digoxin-specific FAB fragments for severe digitalis intoxication in children. N Engl J Med 1992; 326:1739-44
32. 2 antibody fragments. Am Heart J 1979; 98:767-71
33. Bania T, Hoffman RS, Howland MA. Accidental Indian hemp (Apocyneacea cannabinum) cardiac glycoside toxicity [abstract]. Vet Hum Toxicol 1993; 35:328
34. Safadi R, Levy I, Amitai Y, et al. Beneficial effect of digoxin-specific Fab antibody fragments in oleander intoxication. Arch Intern Med 1995; 155:2121-25
35. Shumaik GM, Wu AW, Ping AC, et al. Oleander poisoning: treatment with digoxin-specific FAB antibody fragments. Ann Emerg Med 1988; 17:732-35
36. Rich SA, Libera JM, Locke RJ. Treatment of foxglove poisoning with digoxin-specific FAB fragments. Ann Emerg Med 1993; 22:1904-07
37. Sabourand A, Urtizberea M, Cano N, et al. Specific anti-digoxin Fab fragments: an available antidote for proscillarin and scilliroside poisoning? Hum Exp Toxicol 1990; 9:191-93
38. Bagrov AY, Roukoyatkina NI, Fedorova OV, et al. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factors from the venom of Bufo marinus toad. Eur J Pharmacol 1993; 234:165-72
39. Banner W, Bach P, Burk B, et al. Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment. J Toxicol Clin Toxicol 1992; 30:259-67
40. Rainey PM. Effects of digoxin immune FAB (ovine) on digoxin immunoassays. Am J Clin Pathol 1989; 92:779-86
41. Valdes R, Brown BA, Graves SW. Variable cross-reactivity of digoxin metabolites in digoxin immunoassays. Am J Clin Pathol 1984; 82:210-13
42. Palumbo NE, Perri S, Read BS. Experimental induction and treatment of toad venom poisoning in the dog. J Am Vet Med Assoc 1975; 167:1000-05
43. Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. J Toxicol Clin Toxicol 1973; 6:153-62
44. Dally S, Alperovitch A, Lagier G, et al. Facteurs prognostiques de l'intoxication digitalique aigue. Nouv Presse Med 1981; 10:2257-60
45. Ordog GJ, Benaron S, Bhasin V, et al. Serum digoxin levels and mortality in 5,100 patients. Ann Emerg Med 1987; 16:32-9